Variant report

Variant	nsv876016
Chromosome Location	chr2:234590527-234601669
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:111)
CpG islands
(count:549)
Chromatin interactive
region (count:21)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:111 , 50 per page) page: 1 2 3

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CEBPB	chr2:234598983-234599443	MCF-7	breast:	n/a	n/a
2	CEBPB	chr2:234600119-234600411	MCF-7	breast:	n/a	n/a
3	CEBPB	chr2:234595664-234595804	HepG2	liver:	n/a	n/a
4	CEBPB	chr2:234599021-234599474	Hela-S3	cervix:	n/a	n/a
5	CHD2	chr2:234599081-234599454	Hela-S3	cervix:	n/a	n/a
6	CTCF	chr2:234591309-234591397	GM13976	blood:	n/a	n/a
7	E2F4	chr2:234600126-234600344	MCF10A-Er-Src	breast:	n/a	n/a
8	EP300	chr2:234599017-234599559	Hela-S3	cervix:	n/a	n/a
9	EP300	chr2:234597023-234597315	HepG2	liver:	n/a	n/a
10	EP300	chr2:234598875-234599622	A549	lung:	n/a	n/a
11	EP300	chr2:234598939-234599517	A549	lung:	n/a	n/a
12	FAM48A	chr2:234598904-234599028	GM12878	blood:	n/a	n/a
13	FOS	chr2:234599035-234599524	Hela-S3	cervix:	n/a	n/a
14	FOS	chr2:234599993-234600592	MCF10A-Er-Src	breast:	n/a	n/a
15	FOS	chr2:234599743-234600471	MCF10A-Er-Src	breast:	n/a	n/a
16	FOS	chr2:234599023-234599557	MCF10A-Er-Src	breast:	n/a	n/a
17	FOS	chr2:234599871-234600511	MCF10A-Er-Src	breast:	n/a	n/a
18	FOS	chr2:234590191-234590589	MCF10A-Er-Src	breast:	n/a	n/a
19	FOS	chr2:234599033-234599557	MCF10A-Er-Src	breast:	n/a	n/a
20	FOS	chr2:234599035-234599543	MCF10A-Er-Src	breast:	n/a	n/a
21	FOS	chr2:234595859-234595869	MCF10A-Er-Src	breast:	n/a	n/a
22	FOS	chr2:234590208-234590532	MCF10A-Er-Src	breast:	n/a	n/a
23	FOS	chr2:234599940-234600505	MCF10A-Er-Src	breast:	n/a	n/a
24	FOS	chr2:234599066-234599451	MCF10A-Er-Src	breast:	n/a	n/a
25	FOS	chr2:234590183-234590592	MCF10A-Er-Src	breast:	n/a	n/a
26	FOS	chr2:234598255-234598299	MCF10A-Er-Src	breast:	n/a	n/a
27	FOSL2	chr2:234599043-234599396	A549	lung:	n/a	n/a
28	FOSL2	chr2:234598933-234599481	MCF-7	breast:	n/a	n/a
29	FOSL2	chr2:234598827-234599841	A549	lung:	n/a	n/a
30	FOSL2	chr2:234599051-234599456	MCF-7	breast:	n/a	n/a
31	FOXA1	chr2:234597047-234597404	HepG2	liver:	n/a	n/a
32	FOXA1	chr2:234596953-234597498	HepG2	liver:	n/a	n/a
33	FOXA1	chr2:234597037-234597376	HepG2	liver:	n/a	n/a
34	FOXA1	chr2:234597072-234597409	HepG2	liver:	n/a	n/a
35	FOXA2	chr2:234597024-234597405	A549	lung:	n/a	n/a
36	FOXA2	chr2:234597052-234597363	HepG2	liver:	n/a	n/a
37	GATA1	chr2:234598141-234598711	PBDE	blood:	n/a	n/a
38	GATA1	chr2:234595517-234596094	PBDE	blood:	n/a	chr2:234595870-234595887 chr2:234595574-234595583
39	GATA2	chr2:234598107-234598538	HUVEC	blood vessel:	n/a	n/a
40	GATA3	chr2:234598999-234599503	SK-N-SH	brain:	n/a	chr2:234599154-234599162
41	GATA3	chr2:234599004-234599413	T-47D	breast:	n/a	chr2:234599154-234599162
42	GATA3	chr2:234598791-234599803	A549	lung:	n/a	chr2:234599154-234599162
43	GATA3	chr2:234599032-234599435	SK-N-SH	brain:	n/a	chr2:234599154-234599162
44	GATA3	chr2:234598865-234599680	MCF-7	breast:	n/a	chr2:234599154-234599162
45	GATA3	chr2:234598889-234599641	MCF-7	breast:	n/a	chr2:234599154-234599162
46	GATA3	chr2:234598953-234599780	MCF-7	breast:	n/a	chr2:234599154-234599162
47	GTF2F1	chr2:234599129-234599464	Hela-S3	cervix:	n/a	n/a
48	HDAC2	chr2:234598942-234599469	MCF-7	breast:	n/a	n/a
49	HDAC2	chr2:234598997-234599405	MCF-7	breast:	n/a	n/a
50	JUND	chr2:234599053-234599457	Hela-S3	cervix:	n/a	n/a

(count:549 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:234600147-234600197	GM12892	blood:	n/a
2	chr2:234599988-234600038	HepG2	liver:	n/a
3	chr2:234601254-234601304	SK-N-SH_RA	brain:	n/a
4	chr2:234601254-234601304	PFSK-1	brain:	n/a
5	chr2:234601443-234601493	Jurkat	blood:	n/a
6	chr2:234600149-234600199	NH-A	brain:	n/a
7	chr2:234600149-234600199	ovcar-3	ovarian:	n/a
8	chr2:234600149-234600199	HPAEpiC	pulmonary alveolar:	n/a
9	chr2:234600147-234600197	PFSK-1	brain:	n/a
10	chr2:234590590-234590640	HL-60	blood:	n/a
11	chr2:234600147-234600197	HRCEpiC	kidney:	n/a
12	chr2:234601443-234601493	HNPCEpiC	eye:	n/a
13	chr2:234590590-234590640	GM12892	blood:	n/a
14	chr2:234599026-234599076	AoSMC	blood vessel:	n/a
15	chr2:234601443-234601493	NHDF-neo	bronchial:	n/a
16	chr2:234600147-234600197	AoSMC	blood vessel:	n/a
17	chr2:234601254-234601304	HIPEpiC	eye:	n/a
18	chr2:234601254-234601304	AoSMC	blood vessel:	n/a
19	chr2:234600423-234600473	ECC-1	luminal epithelium:	n/a
20	chr2:234600149-234600199	U87	brain:	n/a
21	chr2:234590590-234590640	GM12878	blood:	n/a
22	chr2:234599988-234600038	HRCEpiC	kidney:	n/a
23	chr2:234601443-234601493	PANC-1	pancreas:	n/a
24	chr2:234600149-234600199	AG09319	gingival:	n/a
25	chr2:234600149-234600199	SK-N-SH	brain:	n/a
26	chr2:234600147-234600197	HCT-116	colon:	n/a
27	chr2:234599026-234599076	SAEC	small airway:	n/a
28	chr2:234601443-234601493	BJ	skin:	n/a
29	chr2:234600147-234600197	Jurkat	blood:	n/a
30	chr2:234600423-234600473	HRE	kidney:	n/a
31	chr2:234601254-234601304	HCM	heart:	n/a
32	chr2:234601254-234601304	GM12878	blood:	n/a
33	chr2:234600149-234600199	HRCEpiC	kidney:	n/a
34	chr2:234600147-234600197	HL-60	blood:	n/a
35	chr2:234599026-234599076	NB4	blood:	n/a
36	chr2:234601443-234601493	GM06990	blood:	n/a
37	chr2:234600423-234600473	AG04450	lung:	fetal
38	chr2:234601443-234601493	MCF10A-Er-Src	breast:	n/a
39	chr2:234600147-234600197	HRE	kidney:	n/a
40	chr2:234600149-234600199	HL-60	blood:	n/a
41	chr2:234590590-234590640	HNPCEpiC	eye:	n/a
42	chr2:234599988-234600038	PANC-1	pancreas:	n/a
43	chr2:234599988-234600038	HEK293	kidney:	embryo
44	chr2:234599026-234599076	AG09319	gingival:	n/a
45	chr2:234601443-234601493	SK-N-SH	brain:	n/a
46	chr2:234590590-234590640	HepG2	liver:	n/a
47	chr2:234590865-234590915	BJ	skin:	n/a
48	chr2:234599026-234599076	GM12878	blood:	n/a
49	chr2:234600423-234600473	AG09319	gingival:	n/a
50	chr2:234601254-234601304	K562	blood:	n/a

(count:21 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr2:234600369..234602177-chr2:234775436..234777156,2	MCF-7	breast:
2	chr2:234464216..234467169-chr2:234597494..234599447,2	MCF-7	breast:
3	chr2:234387197..234390730-chr2:234600088..234603557,3	MCF-7	breast:
4	chr2:234473282..234477495-chr2:234598048..234603332,9	MCF-7	breast:
5	chr2:234590200..234591773-chr2:234592005..234594297,2	MCF-7	breast:
6	chr2:234578802..234581575-chr2:234598668..234600515,2	MCF-7	breast:
7	chr2:234385869..234388276-chr2:234598352..234599952,2	MCF-7	breast:
8	chr2:234474009..234475510-chr2:234594502..234596848,2	MCF-7	breast:
9	chr15:50714595..50716933-chr2:234599004..234601578,2	MCF-7	breast:
10	chr2:234395319..234396920-chr2:234593778..234595799,2	MCF-7	breast:
11	chr2:234599124..234606471-chr2:234613478..234621007,17	MCF-7	breast:
12	chr2:234464967..234466988-chr2:234593051..234595705,2	MCF-7	breast:
13	chr2:234597435..234606028-chr2:234613419..234620116,22	MCF-7	breast:
14	chr2:234356284..234357802-chr2:234598772..234601558,2	MCF-7	breast:
15	chr2:234590573..234592991-chr2:234596085..234597690,2	MCF-7	breast:
16	chr2:234473821..234476593-chr2:234593192..234596119,2	MCF-7	breast:
17	chr2:234472037..234477650-chr2:234599067..234602356,8	MCF-7	breast:
18	chr2:234388753..234400184-chr2:234596527..234603213,35	MCF-7	breast:
19	chr2:234393680..234401613-chr2:234597738..234605139,18	MCF-7	breast:
20	chr2:234591661..234593982-chr2:234613958..234615521,2	MCF-7	breast:
21	chr2:234593709..234597691-chr2:234598690..234601824,5	MCF-7	breast:

No data

Variant related genes	Relation type
UGT1A7	TF binding region
UGT1A6	TF binding region
UGT1A7	CpG island
UGT1A6	CpG island
ENSG00000224814	chromatin interactions
ENSG00000224287	chromatin interactions
ENSG00000241635	chromatin interactions
ENSG00000167165	chromatin interactions
ENSG00000138592	chromatin interactions
ENSG00000077044	chromatin interactions
ENSG00000241119	chromatin interactions
ENSG00000085982	chromatin interactions
ENSG00000244122	chromatin interactions

Extended variants
information (count: 461 )
Associated
traits (count: 61 )

Variant overlapped rSNPs/rCNVs (count:461 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs7586110	chr2:234590527-234590528	Enhancers Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs574890114	chr2:234590529-234590530	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs542729995	chr2:234590532-234590533	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs376801837	chr2:234590538-234590539	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs7577677	chr2:234590616-234590617	Bivalent Enhancer Enhancers Weak transcription	CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs145424374	chr2:234590677-234590678	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs201684360	chr2:234590684-234590685	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs376446155	chr2:234590691-234590692	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs200190624	chr2:234590697-234590698	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs373408916	chr2:234590706-234590707	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs140853286	chr2:234590727-234590728	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs377066301	chr2:234590737-234590738	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs565225309	chr2:234590745-234590746	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs530813077	chr2:234590748-234590749	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs7577789	chr2:234590751-234590752	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs370145562	chr2:234590778-234590779	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs201856078	chr2:234590781-234590782	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs374860015	chr2:234590810-234590811	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs145733073	chr2:234590821-234590822	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs367893933	chr2:234590822-234590823	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs149618508	chr2:234590826-234590827	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs151080578	chr2:234590845-234590846	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs547107317	chr2:234590848-234590849	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs72551331	chr2:234590850-234590851	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs45437497	chr2:234590857-234590858	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs150285310	chr2:234590865-234590866	Enhancers Weak transcription	CpG island	1 gene(s)	Overlapped CNVs	n/a
27	rs182095678	chr2:234590882-234590883	Enhancers Weak transcription	CpG island	1 gene(s)	Overlapped CNVs	n/a
28	rs200147039	chr2:234590889-234590890	Enhancers Weak transcription	CpG island	1 gene(s)	Overlapped CNVs	n/a
29	rs201200762	chr2:234590905-234590906	Enhancers Weak transcription	CpG island	1 gene(s)	Overlapped CNVs	n/a
30	rs149528133	chr2:234590922-234590923	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs61261057	chr2:234590926-234590927	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs140814031	chr2:234590935-234590936	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs56385016	chr2:234590969-234590970	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs71405712	chr2:234590970-234590971	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs397726009	chr2:234590974-234590975	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs66534818	chr2:234590975-234590976	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs114052958	chr2:234591000-234591001	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs72551332	chr2:234591005-234591006	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs183302274	chr2:234591012-234591013	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs375461567	chr2:234591018-234591019	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs368625224	chr2:234591029-234591030	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs544515568	chr2:234591049-234591050	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs140683946	chr2:234591050-234591051	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs139969318	chr2:234591060-234591061	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs529928629	chr2:234591070-234591071	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs540052265	chr2:234591072-234591073	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs560254383	chr2:234591075-234591076	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs188337732	chr2:234591097-234591098	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs28946878	chr2:234591114-234591115	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs201980156	chr2:234591117-234591118	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:61)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Ependymoma	16718352	CNVD
Melanoma	18172304	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	17603634	CNVD
Breast cancer	16272173	CNVD
Ewing''s sarcoma	17952124	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
Colorectal cancer	16272173	CNVD
Lung cancer	18438408	CNVD
Acute myeloid leukemia	20729466	CNVD
small cell lung cancer	20016488	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Urothelial carcinoma	21177765	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cervical cancer	21062161	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Chordoma	18071362	CNVD
Developmental delay	21147756	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Cancer	22429812	CNVD
Bladder cancer	21909424	CNVD
Renal cell carcinoma	21668985	CNVD
Breast cancer	21785460	CNVD
Prostate cancer	18632612	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Wilms tumour	21544195	CNVD
Esophageal adenocarcinoma	18519675	CNVD
prenatal diagnosis	22389664	CNVD
Myelofibrosis	22110671	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Mental retardation	20152051	CNVD
Cancer	21183584	CNVD
Albright''s disease	22277900	CNVD
Brachydactyly-Mental Retardation Syndrome	22470819	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Colorectal cancer	19359472	CNVD
Autism	18414403	CNVD
Chronic myeloid leukemia	21384125	CNVD
Congenital anomalies of the kidney and urinary tract	20605837	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:140 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:234559800-234592800	Weak transcription	Rectal Mucosa Donor 29	rectum
2	chr2:234588000-234593000	Weak transcription	Rectal Mucosa Donor 31	rectum
3	chr2:234588600-234597000	Weak transcription	Sigmoid Colon	Sigmoid Colon
4	chr2:234589000-234590800	Enhancers	Liver	Liver
5	chr2:234589400-234590600	Weak transcription	Esophagus	oesophagus
6	chr2:234589400-234590800	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
7	chr2:234589800-234593000	Weak transcription	A549	lung
8	chr2:234590000-234597800	Weak transcription	Colonic Mucosa	Colon
9	chr2:234590200-234591800	Enhancers	Primary hematopoietic stem cells short term culture	blood
10	chr2:234590600-234590800	Bivalent Enhancer	iPS DF 6.9 Cell Line	embryonic stem cell
11	chr2:234590600-234590800	Enhancers	Esophagus	oesophagus
12	chr2:234590800-234591600	Enhancers	Primary hematopoietic stem cells	blood
13	chr2:234590800-234592600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
14	chr2:234590800-234597400	Weak transcription	Liver	Liver
15	chr2:234590800-234599800	Weak transcription	Esophagus	oesophagus
16	chr2:234591000-234592600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
17	chr2:234591200-234591600	Enhancers	Primary B cells from cord blood	blood
18	chr2:234591600-234597000	Weak transcription	Primary hematopoietic stem cells	blood
19	chr2:234591800-234592200	Weak transcription	Primary hematopoietic stem cells short term culture	blood
20	chr2:234591800-234593000	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
21	chr2:234592200-234592400	Enhancers	Primary hematopoietic stem cells short term culture	blood
22	chr2:234592400-234597200	Weak transcription	Primary hematopoietic stem cells short term culture	blood
23	chr2:234592600-234595600	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
24	chr2:234592600-234597000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
25	chr2:234592800-234593200	Enhancers	Rectal Mucosa Donor 29	rectum
26	chr2:234593000-234593200	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
27	chr2:234593000-234593200	Enhancers	A549	lung
28	chr2:234593000-234594400	Enhancers	Rectal Mucosa Donor 31	rectum
29	chr2:234593200-234594000	Weak transcription	A549	lung
30	chr2:234593200-234598400	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
31	chr2:234594200-234595000	Weak transcription	A549	lung
32	chr2:234594400-234597600	Weak transcription	Rectal Mucosa Donor 31	rectum
33	chr2:234595400-234595800	Enhancers	Stomach Mucosa	stomach
34	chr2:234595400-234595800	Enhancers	Hela-S3	cervix
35	chr2:234595600-234595800	ZNF genes & repeats	A549	lung
36	chr2:234595600-234596000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
37	chr2:234595800-234596800	Weak transcription	Stomach Mucosa	stomach
38	chr2:234595800-234597000	Weak transcription	A549	lung
39	chr2:234595800-234597400	Weak transcription	Hela-S3	cervix
40	chr2:234596000-234597000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
41	chr2:234596800-234600600	Enhancers	Stomach Mucosa	stomach
42	chr2:234597000-234597200	Enhancers	iPS-18 Cell Line	embryonic stem cell
43	chr2:234597000-234597600	Enhancers	iPS-20b Cell Line	embryonic stem cell
44	chr2:234597000-234597800	Enhancers	Gastric	stomach
45	chr2:234597000-234598400	Enhancers	Primary hematopoietic stem cells	blood
46	chr2:234597000-234598400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
47	chr2:234597000-234598600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
48	chr2:234597000-234599000	Enhancers	A549	lung
49	chr2:234597000-234600400	Enhancers	Sigmoid Colon	Sigmoid Colon
50	chr2:234597200-234597800	Weak transcription	iPS-18 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links